BAXTER INTERNATIONAL INC acquires Cheetah Medical, Inc. (Cheetah)

BAXTER INTERNATIONAL INC acquired Cheetah Medical, Inc. (Cheetah) for $188 million total cash consideration net of cash acquired, plus up to $40 million of contingent consideration (acquisition-date fair value $18 million), a transaction completed in October 2019, structured as all cash (with contingent consideration).

Cheetah Medical, Inc. (Cheetah) operates in Patient monitoring / hemodynamic monitoring, is based in Newton Center, Massachusetts, USA. Cheetah Medical is a provider of non-invasive fluid management and hemodynamic monitoring technologies used to guide fluid administration decisions in critical and surgical care.

Adds non-invasive hemodynamic monitoring and fluid management technology that complements Baxter's acute care and critical-care portfolio.

Non-invasive hemodynamic monitoring technology complementary to Baxter's acute and critical-care therapies. Integrated into Baxter's acute care / critical care business